Tabula Rasa HealthCare, Office of Translational Research and Residency Programs, Moorestown, New Jersey, USA
Case Report
Pharmacists Role in Deprescribing Medications in An Adult with End-Stage Kidney Disease
Author(s): Aashish Sreeram, Adriana Matos, Nishita Shah Amin, Jacques Turgeon, Katie Meyer and Chandni Bardolia*
Purpose: Individuals diagnosed with End-Stage Kidney Disease (ESKD) have multiple comorbidities and require many medications. Alterations in
renal function, coupled with pharmacokinetic and pharmacodynamic changes in individuals with increasing age, can result in adverse drug effects.
The purpose of this case is to demonstrate how interventions recommended by a clinical pharmacist improved medication safety for a patient with
ESKD.
Case: A 55-year-old male with a past medical history of ESKD, peripheral artery disease, chronic heart failure, cirrhosis, and major depressive
disorder had a clinical pharmacist-led medication review. During the review, the clinical pharmacist identified several medications (i.e., bumetanide,
metolazone, spironolactone, rivaroxaban) that should be discontinued since the patient had no urinary fl.. Read More»
DOI:
10.37421/2165-7920.2021.11.1465
Journal of Clinical Case Reports received 1295 citations as per Google Scholar report